Kahn is a particular fan of the peptides NAD+ and glutathione—which, she says, “work synergistically to help with energy, ...

When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

3 Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), and tirzepatide is a dual GLP-1 RA and glucose-dependent insulinotropic polypeptide. However, with evidence that there are ...

A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...